Etolid Tablet ER contains Etodolac 600mg, a nonsteroidal anti-inflammatory drug (NSAID) used primarily to relieve pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Etodolac works by inhibiting cyclooxygenase (COX) enzymes, which play a key role in the synthesis of prostaglandins, substances responsible for pain, fever, and inflammation. The extended-release (ER) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and improving patient compliance by reducing the frequency of dosing. Etolid Tablet ER is effective in managing moderate to severe pain and inflammation, helping to improve joint function and overall mobility. It is important to take this medication with food or milk to minimize gastrointestinal discomfort, a common side effect of NSAIDs. Patients with a history of gastrointestinal ulcers, bleeding disorders, kidney or liver impairment, or cardiovascular diseases should use Etolid Tablet ER cautiously and under medical supervision. Common side effects may include nausea, dizziness, headache, and abdominal pain. Regular monitoring by a healthcare professional is recommended during prolonged use to detect any adverse effects early. Etolid Tablet ER should be used as directed by a physician to ensure safety and efficacy.